Beginner
- Dose
- 250 mcg por dia Original in PT-BR
- Frequency
- Diária, subcutânea Original in PT-BR
- Duration
- Semanas 1–4 Original in PT-BR
- Notes
- Padrão comunitário relatado; sem validação humana. Original in PT-BR
KNOWLEDGE · COMPOUNDS
FOXO4-DRI
Also known as: Proxofim
LongevityPreclinical
Overview
Written by EagleThis description was written by Eagle in each of the three languages. It is not imported text and carries no translation warning. What it says comes from the compound’s own composition, its pharmacological class and what the library records — no efficacy claim, and no Eagle recommendation of use.
Os dados apresentados são de células e camundongos; o site declara ausência de ensaios humanos até junho de 2026.
FOXO4-DRI is catalogued under Longevity. 0 Eagle articles in this library reference this compound.
- Category
- Longevity
- Research stage
- Preclinical — Pré-clínico Original in PT-BR
- Eagle articles on this compound
- 0 Eagle articles
Mechanism
O site descreve FOXO4-DRI como um peptídeo senolítico estudado para interromper a interação FOXO4–p53. Original in PT-BR
Chemical information
- CAS
- Not recorded in the source.
- Molecular formula
- Not recorded in the source.
- Molecular weight
- Not recorded in the source.
- Sequence
- Not recorded in the source.
- Amino acids
- Not recorded in the source.
- Solubility
- Not recorded in the source.
- Stability
- Not recorded in the source.
- Half-life
- Not recorded in the source.
- Bioavailability
- Not recorded in the source.
- Onset
- Not recorded in the source.
- Routes
- Intraperitoneal em camundongos · Subcutânea em padrões comunitários
Research references
No individual dosing recommendation is given. Values are as recorded in the source, with species and route stated where known.
No research references recorded in the source.
Safety
No safety information recorded in the source.
Reported protocols
Recorded in the imported source as community protocols. They are NOT Eagle protocols, were not reviewed by Eagle, and are not a dosing recommendation, a prescription or clinical guidance. Values appear exactly as recorded, in the language they were written in.
Intermediate
- Dose
- 375 mcg por dia Original in PT-BR
- Frequency
- Diária, subcutânea Original in PT-BR
- Duration
- Semanas 5–8 Original in PT-BR
- Notes
- Padrão comunitário relatado; sem validação humana. Original in PT-BR
Advanced
- Dose
- 500 mcg por dia Original in PT-BR
- Frequency
- Diária, subcutânea Original in PT-BR
- Duration
- Semanas 9–16 Original in PT-BR
- Notes
- O site também cita 5 mg/kg intraperitoneal cerca de três vezes por semana em camundongos; isso é animal, não equivalente humano. Original in PT-BR
Vial sizes: 10 mg — Peptide Calculator
Interactions
No relations recorded in the source.
Related
No Eagle article in this library references this compound yet.